ADVERTISEMENT

Pot ETFs Make Millions From Short Sellers for Year’s Best Gains

Pot ETFs Make Millions From Short Sellers for Year’s Best Gains

(Bloomberg) -- Exchange-traded funds that invest in cannabis companies are hitting the jackpot with a little help from short sellers.

The two largest pot ETFs in North America -- the Horizons Marijuana Life Sciences Index ETF and the ETFMG Alternative Harvest ETF -- have made millions of dollars lending out their holdings to traders who want to bet against this year’s 60 percent climb in the red-hot market for cannabis stocks. Both funds returned more than 45 percent in the first quarter, beating almost all non-leveraged ETFs in North America, data compiled by Bloomberg show.

Pot ETFs Make Millions From Short Sellers for Year’s Best Gains

While many ETFs engage in securities lending, it’s been a particularly lucrative practice for pot funds as many cannabis stocks have a small public float and aren’t readily available to borrow. The funds charge a fee to borrow the shares, generating additional income that can help boost their performance.

“There’s a lot of people that don’t believe in this sector from a long-term growth perspective and are trading on that volatility,” Steve Hawkins, president and chief executive of Horizons ETFs Management Canada, said on Bloomberg TV last week. “They’re coming to us because we are the largest institutional holder of a lot of these companies.”

Pot securities cost about 15 percent to borrow versus typical rates closer to 1 percent for more prosaic shares, according Bloomberg Intelligence analysis. But borrow fees can rise to as high as 110 percent for popular short targets like Tilray Inc.

Canadian ETFs can lend out as much as 50 percent of their holdings, while U.S. funds are capped at 33 percent, according to Bloomberg Intelligence.

Best Performers

The Horizons fund -- the first pot ETF and Canada’s biggest -- gained 53 percent in the first quarter, making it one of North America’s best-performing ETFs.

Securities lending boosted its performance by approximately 1.1 percentage point in the first two months of the year, translating into a 7 percent yield on an annualized basis, a Horizons ETFs spokesman said. The fund, known as HMMJ, netted C$51.5 million ($38 million) lending out its stocks to short sellers last year, with C$16.8 million of that coming in the fourth quarter, the issuer said.

ETFMG Alternative Harvest ETF, known by its ticker MJ, has also reaped the benefits of securities lending. The fund gained 46 percent in the first quarter, more than any other unleveraged U.S. fund, data compiled by Bloomberg show.

Income from short sellers added 0.58 percentage point to MJ’s overall performance in the first three months of the year, according to Sam Masucci, chief executive of ETF Managers Group, which runs the fund. Securities lending generated about 2 percentage points -- more than $9 million -- for MJ’s shareholders in 2018, Masucci said.

‘Double Whammy’

Securities lending is however only part of the story, according to Bloomberg Intelligence analyst Eric Balchunas. Neither HMMJ nor MJ own U.S. pot stocks as such businesses are illegal under federal law. With these cannabis producers lagging over the last year, that’s helped HMMJ beat the North American Marijuana Index -- which covers Canadian and U.S. companies -- but that advantage could fade. Horizons recently disclosed plans for a fund that will contain only U.S. licensed producers.

Pot ETFs Make Millions From Short Sellers for Year’s Best Gains

“These funds have the double positive whammy of securities lending and U.S. pot stocks trailing Canadian ones,” said Bloomberg’s Balchunas. “If U.S. pot stocks rally, it’s possible some of this boost goes away, because the securities lending benefits may be overwhelmed by the funds not holding the U.S. stocks.”

--With assistance from Tom Lagerman.

To contact the reporters on this story: Kristine Owram in Toronto at kowram@bloomberg.net;Carolina Wilson in New York City at cwilson166@bloomberg.net

To contact the editors responsible for this story: Brad Olesen at bolesen3@bloomberg.net, ;Jeremy Herron at jherron8@bloomberg.net, Rachel Evans, Rita Nazareth

©2019 Bloomberg L.P.